BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
60.00
+1.05 (1.78%)
At close: Jul 16, 2026, 4:00 PM EDT
59.95
-0.05 (-0.08%)
Pre-market: Jul 17, 2026, 4:57 AM EDT

BioMarin Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
11,59711,42812,53918,18519,27516,249
Market Cap Growth
10.01%-8.86%-31.05%-5.66%18.63%1.96%
Enterprise Value
10,81410,46511,99618,19819,06716,314
Last Close Price
60.0059.4365.7396.42103.4988.35
PE Ratio
42.9633.0229.74110.83137.99-
Forward PE
10.6812.3717.8638.9839.0085.79
PEG Ratio
0.370.650.721.070.862.66
PS Ratio
3.583.554.397.529.208.80
PB Ratio
1.871.882.223.674.193.81
P/TBV Ratio
2.012.072.484.144.814.39
P/FCF Ratio
15.1215.7625.72290.64350.8277.76
P/OCF Ratio
13.2713.8021.89114.18109.5853.36
EV/Sales Ratio
3.343.254.207.529.108.84
EV/EBITDA Ratio
17.1321.4020.6662.7272.51634.83
EV/EBIT Ratio
19.1525.5624.7797.96118.45-
EV/FCF Ratio
14.1014.4424.61290.85347.0378.07
Debt / Equity Ratio
0.230.100.110.220.240.25
Debt / EBITDA Ratio
3.681.221.023.754.1241.99
Debt / FCF Ratio
1.870.821.2217.3719.715.16
Net Debt / Equity Ratio
-0.13-0.16-0.100.00-0.040.02
Net Debt / EBITDA Ratio
-2.04-1.97-0.930.05-0.792.54
Net Debt / FCF Ratio
-1.03-1.33-1.110.21-3.790.31
Asset Turnover
0.400.440.410.370.340.31
Inventory Turnover
0.590.570.500.530.600.64
Quick Ratio
3.943.252.961.452.982.54
Current Ratio
5.815.215.332.514.674.16
Return on Equity (ROE)
4.37%5.94%8.05%3.51%3.19%-1.53%
Return on Assets (ROA)
2.71%4.06%5.52%2.50%2.46%-1.18%
Return on Invested Capital (ROIC)
4.17%5.78%7.57%3.53%3.49%-1.66%
Return on Capital Employed (ROCE)
4.31%6.20%8.04%3.24%2.86%-1.52%
Earnings Yield
2.32%3.03%3.36%0.90%0.72%-
FCF Yield
6.61%6.34%3.89%0.34%0.29%1.29%
Buyback Yield / Dilution
-0.86%-0.35%-2.67%-1.39%-3.34%4.60%
Total Shareholder Return
-0.86%-0.35%-2.67%-1.39%-3.34%4.60%
SEC Filings: 10-K · 10-Q